We are currently looking for a Senior Scientist, Mechanistic Pharmacology in Translational Research (complex in vitro models cardiovascular and renal indications) to join our team in Schlieren, ZH. **Key Tasks** * Develop, optimize, and apply advanced cellular and complex in vitro models with translational relevance for cardiovascular and renal indications * Provide scientific leadership in the selection, establishment, and use of cellular model systems to support translational project objectives. * Design and execute functional assays to generate high-quality data for target validation, mechanistic studies, and characterization of therapeutic candidates. * Interact with project teams, communicating data, insights, and recommendations clearly to colleagues and stakeholders. * Support external collaborations and outsourcing activities where needed, ensuring scientific quality and alignment with project goals. **Your Profile** * Postgraduate degree in Life Sciences, Pharmacology, Cell Biology, or a related scientific discipline; a PhD is preferred. * At least 3 years of relevant experience in industry or a comparable academic research environment focused on cardiovascular or kidney biology * Strong expertise in complex cellular model systems (ipsc, co-culture, organoids and/or organ-on-a-chip) and translationally relevant in vitro assay development. * A problem-solving mindset with the ability to define critical scientific questions and translate them into effective experimental strategies. * Demonstrated ability to present scientific data and concepts clearly to colleagues, cross-functional teams, and management. * Strong interpersonal skills with the ability to collaborate effectively across internal teams and external partners. * A proactive, hands-on, and solution-oriented approach, combined with a curious and disciplined mindset * Strong collaborative mindset, with the flexibility to work effectively across teams and with different project stakeholders. CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/. At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.